A study by Iman Mamdouh Talaat et al. tentatively demonstrated that bone marrow horse injection hemoglobin-1 (SCGB2A2) can be used as a tool to study breast cancer early BM. This evidence concerns the gene SCGB2A2 and breast cancer.